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Introduction
Carbapenem Resistant Enterobacteriaceae (CRE) have
emerged in surgical (SW) and intensive care units
(ICUs) of tertiary health care centers in North West
Nigeria despite their low or no usage in the hospitals.
Objectives
1. To determine the antibacterial susceptibility of patho-
gens from patients with severe bacterial infections that
require rapid and aggressive antimicrobial treatments to
imipenem (IMP) and meropenem (MEM) 2. Screen the
pathogens for carbapenemase and metallo bêta lactamase
production 3. Tests their susceptibility to colistin and
tigecycline. 4. To evaluate the views of by different health
care practitioners on causes, effects and control of CRE.
Methods
Isolates from patients admitted for atleast 7 days were
screened for susceptibility to IMP and MEM using the
CLSI 2012 break points. Carbapenemase and Metallo-b-
lactamase (MBL) production were detected phenotypically
by Modified Hodge Test (MHT) and Combine Disc Test
(CDT) respectively.
Results
Resistance to IMP and MEM was 10.5% and 12.5%
respectively. Carbapenemase production was 34.5%
(highest so far in Kano). About 14.4% of the carbapene-
mase producers produce MBL. All the isolates were sus-
ceptible to colistin and tigecycline, except 2 E. coli and
1 K. pneumoniae which are resistant and also none car-
bapenemase producers. Of 486 medical practitioners stu-
died in the region, only 1.2% have previous knowledge
that MBL causes resistance. About 24.5%, 5.9% and 3.9%
have knowledge of ESBL, AmpC and carbapenemase as a
cause of rising resistance in the state. In addition, only
38.2% doctors have ever prescribe carbapenems in their
professional practices and 12.8% of the doctors only pre-
scribe in a ratio of 1:20 due to its high cost.
Conclusion
Carbapenem resistance is in increase in hospitals with a
low or no usage of carbapenem and the resistances are
mediated by carbapenemase especially MBL. Awareness
of this problem is low among the medical practitioners
that have direct contact with the patients and can contri-
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